undefined undefined
NaN.000
NaN.00%
Pyxis Oncology (NASDAQ:PYXS) said it has completed the sale of its rights to royalties from the commercialization of Beovu and another asset to Novartis for a one-time cash payment of $8 million. The ...
03-27 19:43
先聲藥業(02096.HK)公布,注射用蘇維西塔單抗新藥上市申請獲中國國家藥品監督管理局受理,適應症為蘇維西塔單抗聯合化療用於含鉑化療治療失敗的復發性卵巢癌、輸...
03-17 20:18
格隆汇3月15日丨先声药业(02096.HK)公告,2024年3月15日,注射用苏维西塔单抗新药上市申请获中国国家药品监督管理局(NMPA)受理,适应症为苏维西...
03-15 21:16
纵观整个商业发展史,破产、倒闭是绝大多数创业公司的宿命。但是,上市公司、独角兽、获得过多轮大额融资的明星公司在短期内接连宣布破产,就显得不那么正常了。 根据外媒...
2023-11-20 13:38
“并购*”丹纳赫再次出手:8月28日,丹纳赫集团宣布与全球*的蛋白质耗材供应商Abcam达成协议,以每股24美元的现金收购Abcam的所有流通股,交易总价或达到...
2023-08-31 10:47
Gainers HeartBeam (NASDAQ:BEAT) stock rose 20.1% to $2.42 during Thursday's pr...
2023-05-25 21:07
NEW YORK, May 24, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or ...
2023-05-25 00:37
Pyxis Oncology (NASDAQ:PYXS) has announced an acquisition of Apexigen (NASDAQ:APGN) that is expected to be completed in the second half of 2023.
2023-05-25 00:19
Apexigen shares are trading higher after Pyxis Oncology announced it will acqui...
2023-05-24 20:35
Pyxis Oncology positioned at forefront of Antibody-Drug Conjugate (ADC) develop...
2023-05-24 18:45